Application no. and date | 15198284.0 (espacenet) (Federated) (European Patent Register), 20110516 | Patent/reg. no. and date | DK/EP 3023788, 20200212 | Publication date | 20160525 | Priority no. and date | US 334866 P, 20100514 | EP pub. no. and date |
EP 3023788 20160525 | Effective date | | Applicant/owner | The General Hospital Corporation, 55 Fruit Street Boston, MA 02114, US, Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue
Boston, MA 02215, US | Applicant ref. no. | V47465DK00 | Inventor | HACOHEN, Nir, 117 Mason Terrace
Brookline, MA 02446, US, WU, Catherine, 117 Mason Terrace
Brookline, MA 02446, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 39/00 (2006.01) , A61P 35/00 (2006.01) , G01N 33/68 (2006.01) | Title | Sammensætninger af tumorspecifikke neoantigener til anvendelse ved behandling af tumorer | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|